Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-alpha-acetyltransferase 40 (NAA40, also called NatD catalytic subunit) is a protein acetyltransferase enzyme that specifically catalyzes N-terminal acetylation of histones H4 and H2A, thus regulating chromatin structure and gene expression[1][3][6]. Unlike other N-terminal acetyltransferases, NAA40 shows high substrate specificity, targeting the Ser-Gly-Arg-Gly N-terminus of H4 and H2A. NAA40 is localized primarily in the nucleoplasm and cytosol and is involved in chromatin remodeling, developmental regulation, and the suppression of apoptosis. Genetic and functional studies in human and model organisms indicate key roles in developmental transitions and potential contributions to diseases such as cancer and rare congenital anomalies[1][2][5][6].
Inhibitors would potentially block N-terminal acetylation of target histones, altering chromatin states and gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-alpha-acetyltransferase 40, NatD catalytic subunit (NAA40).